Urmăriți
Sangita Pal
Sangita Pal
Dana-Farber Cancer Institute, Harvard Medical School
Adresă de e-mail confirmată pe dfci.harvard.edu
Titlu
Citat de
Citat de
Anul
Epigenetics and aging
S Pal, JK Tyler
Science advances 2 (7), e1600584, 2016
8922016
Mechanisms and therapeutic implications of hypermutation in gliomas
M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ...
Nature 580 (7804), 517-523, 2020
5622020
Nucleosome loss leads to global transcriptional up-regulation and genomic instability during yeast aging
Z Hu, K Chen, Z Xia, M Chavez, S Pal, JH Seol, CC Chen, W Li, JK Tyler
Genes & development 28 (4), 396-408, 2014
3472014
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
OM Enache, V Rendo, M Abdusamad, D Lam, D Davison, S Pal, ...
Nature genetics 52 (7), 662-668, 2020
2712020
Influenza A virus interacts extensively with the cellular SUMOylation system during infection
S Pal, A Santos, JM Rosas, J Ortiz-Guzman, G Rosas-Acosta
Virus research 158 (1-2), 12-27, 2011
972011
SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization
A Santos, S Pal, J Chacón, K Meraz, J Gonzalez, K Prieto, ...
Journal of virology 87 (10), 5602-5620, 2013
652013
Cross-talk between lysine-modifying enzymes controls site-specific DNA amplifications
S Mishra, C Van Rechem, S Pal, TL Clarke, D Chakraborty, SD Mahan, ...
Cell 174 (4), 803-817. e16, 2018
602018
Impaired cohesion and homologous recombination during replicative aging in budding yeast
S Pal, SD Postnikoff, M Chavez, JK Tyler
Science advances 4 (2), eaaq0236, 2018
552018
Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs
S Pal, JM Rosas, G Rosas-Acosta
Journal of virological methods 163 (2), 498-504, 2010
462010
Epigenetics and aging. Sci. Adv. 2016; 2 (7): e1600584
S Pal, JK Tyler
32
VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system
J So, NW Mabe, B Englinger, KH Chow, SM Moyer, S Yerrum, MC Trissal, ...
JCI insight 7 (19), e158755, 2022
202022
Proteomic identification of histone post-translational modifications and proteins enriched at a DNA double-strand break
P Wang, S Byrum, FC Fowler, S Pal, AJ Tackett, JK Tyler
Nucleic acids research 45 (19), 10923-10940, 2017
202017
Delineation of the role of chromatin assembly and the Rtt101Mms1 E3 ubiquitin ligase in DNA damage checkpoint recovery in budding yeast
LT Diao, CC Chen, B Dennehey, S Pal, P Wang, ZJ Shen, A Deem, ...
PloS one 12 (7), e0180556, 2017
202017
The Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila Cells
S Pal, H Graves, R Ohsawa, T Huang, P Wang, L Harmacek, J Tyler
PLoS One 11 (5), e0155409, 2016
192016
Author correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations
OM Enache, V Rendo, M Abdusamad, D Lam, D Davison, S Pal, ...
Nature Genetics 52 (7), 748-749, 2020
162020
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma
V Rendo, EQ Lee, C Bossi, N Khuu, MA Rudek, S Pal, ARN Reynolds, ...
medRxiv, 2024.08. 12.24311893, 2024
2024
20/# 1057 Integrated profiling of a prospective endometrial cancer organoid biobank reveals high heterogeneity
H Berg, M Hjelmeland, H Lien, H Espedal, S Pal, A Srivastava, T Stokowy, ...
International Journal of Gynecological Cancer 32, A34-A35, 2022
2022
EXTH-95. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS
S Pal, A Boynton, R Johnston, N Currimjee, K Qian, M Touat, C Bellamy, ...
Neuro-Oncology 24 (Supplement_7), vii231-vii232, 2022
2022
HGG-32. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS
A Boynton, S Pal, M Touat, N Currimjee, K Qian, C Bellamy, P Ho, ...
Neuro-Oncology 22 (Suppl 3), iii349, 2020
2020
DRES-08. CLINICAL SIGNIFICANCE OF HYPERMUTATION IN GLIOMAS
M Touat, Y Li, A Boynton, L Spurr, B Iorgulescu, C Birzu, S Pal, ...
Neuro-oncology 21 (Supplement_6), vi73-vi73, 2019
2019
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20